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1. Introduction 
It is really impossible to estimate the volume of ink that has been spent writing about 
Salmonella since its first description in 1885, by Daniel D. Salmon. Nowadays, performing a 
search on this bacterial genus using web databases originates more than 17 million 
references. Before the web era, the dissemination of information on Salmonella was 
extremely complex or even impossible, and this is probably the reason why Salmonella 
taxonomy has been so difficult to establish during the first century after its description. The 
taxonomy of this bacterial genus still today remains under revision. 
Sadly, Salmonella is the paradigm of a popular microbe by quite regrettable reason: from the 
most common citizen to the most qualified microbiologist, everyone has already talked 
about Salmonella. The reason for this is, surely, its incrimination on severe food poisoning 
outbreaks and in many cases of illness in humans and animals and mortality in humans and 
animals. 
Epidemiological data indicate that the cases of human or animal infections by Salmonella are 
may assume a dramatic dimension. In the European Union, the number of reported human 
cases is approximately 150 thousand each year, with a consistent tendency to decline during 
the last four years. In countries where basic health care cannot be delivered, the most 
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dangerous clinical expression of a Salmonella infection, Typhoid fever, affects 16 million 
people per year, with almost 500,000 fatal cases, as estimated by the World Health 
Organization (Pang et al., 1998). 
In fact, not all Salmonella isolates identified worldwide have such devastating consequences 
to human or animal health. Some of the Salmonella seroptypes or serovars are strictly 
adapted to primates (Salmonella Typhi, Salmonella Paratyphi, Salmonella Wien) being referred 
to as prototrophic for man; others are strictly adapted to some animal species (Salmonella 
Gallinarum-Pullorum, Salmonella Abortusovis, Salmonella Abortusequi), being referred to as 
prototrophic to animals; however, the vast majority of the serotypes are zoonotic, being able 
to infect both animals and humans. Salmonella varieties differentiation is based on its 
antigenic mosaic, in a complex combination of somatic (O), flagelar (H) and capsular (Vi) 
antigens. Serotyping according to the Kauffmann-White system, established in the middle of 
the last century, is still recognized as the reference method for discrimination of Salmonella 
varieties. Each combination of different antigens found in a particular Salmonella isolate 
(serotype or serovar) has a specific designation, following the international nomenclature 
based on one hundred years of scientific contributions, which sometimes originated peculiar 
designations (Popoff & Le Minor, 1997; Grimont & Weill, 2007). 
Salmonella is an infectious and contagious bacterium that may be transmitted to humans, 
warm blood animals and reptiles by contaminated drinking water, by raw foods 
consumption, by direct contact with previously infected humans or animals and by 
iatrogenic accidents. 
Food, in particular raw food, is the most common pathway for Salmonella infection, 
especially by zoonotic serotypes. Since the 1950’s, zoonotic Salmonella became dominant in 
human salmonellosis cases. Virulence is strictly dependent on the serotype and it also varies 
with individual competences of each bacterial strain and with host susceptibility. These 
features explain why some serotypes have a higher prevalence in a particular host. In the 
last decades, two serotypes of zoonotic Salmonella showed a clear dominant incidence: 
Salmonella Typhimurium, firstly found in bovines, pigs, pigeons and secondarily in humans, 
while Salmonella Enteritidis, more common in poultry, but firstly found in humans, with the 
exception of Europe (EFSA, 2010b). These two serotypes may be discriminated more deeply 
using epidemiological markers like phage typing, molecular genotyping or other 
methodologies, including profiling for antimicrobial resistance phenotypes (R-type). 
Salmonella Typhimurium is a somatic group B strain with the following antigenic formula: 
4,[5],12:i:1,2. It has been early recognized as a serotype with a variable antigenic structure, 
like the lack of the somatic antigen [5], assuming, in this case, the designation of “variety 
Copenhagen” (very frequent in pigeons and bovines). The antigenic structure modulation of 
Salmonella Typhimurium may be mediated by plasmids, phages or proto-phages infections 
or segregations. 
By the end of the 1980s, some isolates of a monophasic form of Salmonella Typhimurium - 
serotype I,4,[5],12:i:- gained epidemiological relevance, being more and more frequently 
referred to in the literature (Machado & Bernardo, 1990). The prevalence of this monophasic 
serotype has grown, presently being one of the most common Salmonella serotypes isolated 
from humans in several countries (Hopkins, et al., 2010) (Table 1). Other variants have also 
been found: variants lacking the 1st flagellar phase or lacking both (i and 1,2); and also 
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variants without the somatic 1 antigen. The possibility that before the 1990s the scarce 
reports of Salmonella I,4,[5],12:i:- isolation, may reflect the difficulties in serotyping it  being 
the isolates probably designated as Salmonella Typhimurium. At that time it was frequent to 
report some Salmonella serotypes as “Group B” or “untypable” (Switt et al., 2009). 
 
Years of isolation Country Source
1986 Portugal Chicken carcasses 
1993 Thailand Human
1997 Spain Human
1991 Brazil Human
1998 United States Human
2000 Germany Human, food, swine, cattle, broiler 
2003 Italy Human, swine
2005 UK Human
2006 Luxembourg Pork, pigs
Table 1. First time reports of Salmonella 4,[5],12:i: isolation (Adapted from EFSA, 2010b) 
2. Occurrence of Salmonella I,4,[5],12:i:- 
Cases of human infections with serovar I,4,[5],12:i:- have been related to severe illnesess. 
This serovar was responsible for an outbreak in New York City in 1998, in which 70% of the 
cases required hospitalization, being also associated with cases of systemic infections in 
Thailand and in Brazil (Switt et al., 2009). 
Some foodborne outbreaks due to Salmonella I,4,[5],12:i:- have been reported in Europe. In 
2006, Luxembourg signaled two outbreaks caused by a monophasic S. Typhimurium DT 
193, corresponding to 133 human cases, 24 hospitalizations and one death (Mossong et al., 
2007). Pork meat has been incriminated in these Salmonella cases (Mossong et al., 2007).  
In Germany, the number of Salmonella I,4,[5],12:i:- related with human diseases has 
increased since 2000 (Hauser et al., 2010). Since 2006, the same monophasic variant of the 
multidrug-resistant Salmonella DT 193 strain has been associated with sporadic cases of 
salmonellosis, with increasing rates of hospitalization (Trupschuch et al., 2010). In 2008, the 
monophasic I,4,[5],12:i:- variant correspond to up to 42% of all S. Typhimurium isolates 
responsible for human salmonellosis (Hauser et al., 2010). 
In France, official data suggest a gradual increase of Salmonella I,4,[5],12:i:- isolation rate in  
humans. After 2005, the frequency of this particular serovar raised from the eleventh to the 
third place (AFSSA, 2009) and a further significant increase was reported in the first five 
months of 2010 (Bone et al., 2010). In 2008, several outbreaks of Salmonella I,4,[5],12:i:- 
infections were identified in this country, including 13 family outbreaks, three collective 
infections and two hospital infections (AFSSA, 2009). 
In Spain, the number of Salmonella I,4,[5],12:i:- illness cases has consistently increased since 
1997, the year of the first report. Nowadays, the monophasic Salmonella is at the top five 
among the most frequently isolated Salmonella serovars in Spain (de la Torre et al., 2003). 
The epidemiological relevance of this serotype makes it a major cause of concern in Spain 
since the beginning of this Century (Echeita, et al., 1999; Guerra, et al., 2000). 
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In the UK, human infections by Salmonella I,4,[5],12:i:- began to be reported in 2005, when 47 
cases occurred. In 2009 151 cases occured, representing an increase of more than 30%. 
Almost 30 % of the Salmonella I,4,[5],12:i:- isolates had a R-type ASSuT. In Scotland there was 
also an increase in the number of reports of Salmonella monophasic Group B cases. 
Since 2008, sporadic and diffuse outbreaks related with ready to eat food have also been 
described in the UK linked to a DT 191A Salmonella I,4,[5],12:i:- strain, which is tetracycline-
resistant (Peters et al., 2010). This strain is thought to have originated from infected frozen 
feeder mice imported into the UK for feeding exotic pets. 
In Italy, Salmonella I,4,[5],12:i:- is one of the most frequent serotypes related to human cases 
of salmonellosis (Dionisi et al., 2009). R-type ASSuT represented 75% of the monophasic 
isolates identified in 2008 and 2009. Almost 50 % of the monophasic isolates were identified 
as Salmonella DT193 and 13% as Salmonella U302. 
In The Netherlands, S. I,4,[5],12:i:- was related to human cases for the first time in 2004. 
After that, the number of cases has consistently grown, being the third most prevalent 
serotype responsible for human salmonellosis from 2005 to 2008 (Van Pelt et al., 2009). 
There also many cases reported outside Europe. In the USA, Salmonella I,4,[5],12:i:- 
frequency in human infections has consistently increased from 2002, being now ranked in 
the top six. During 2007, some Salmonella I,4,[5],12:i:- outbreaks occurred in the USA, related 
to frozen chicken pies consumption and also to direct contact with turtles kept as pets (CDC, 
2007a, 2007b). 
Some cases have also been reported in Canada (Switt et al., 2009). 
Salmonella I,4,[5],12:i:- has also been reported in Brazil quite  early, in the 1970s.  In São Paulo 
State, the occurrence of the strain in human infections was reported in the 1990s. Since then, 
the frequency of foodborne outbreaks and of extra-intestinal infections in humans promoted 
by this serovar showed a consistent tendency to increase (Tavechio et al., 2009). 
In Thailand, Salmonella I,4,[5],12:i:- has been classified among the top five Salmonella serovars 
responsible for cases of foodborne salmonellosis (Amavisit, et al., 2005; Pornruangwong et 
al., 2008). 
Human cases of infection with this particular serotype seem to be generally linked to raw 
meat. According to the EFSA zoonoses reports, in 2008 Salmonella I,4,[5],12:i:- has been 
related to 3.1% of Salmonella isolations in pig herds; in 2009, the same serotype has been 
found in 1.2% of the Salmonella positive bovine herds, 3.2% of positive pig herds and 
represented 1.4% of Salmonella isolations in poultry meat. 
A particularly relevant feature of Salmonella I,4,[5],12:i:- is the fact that most virulent isolates 
exhibit a plasmid-mediated resistance to a wide range of antimicrobial compounds. Similar 
to its ancestral lineage - Salmonella Typhimurium DT104 - the monophasic strain I,4,[5],12:i:- 
frequently expresses a multiple resistance to ampicillin (A), streptomycin (S), 
sulphonamides (Su) and tetracyclines (T). This ASSuT antimicrobial resistance pattern is 
chromosomally-encoded (Hopkins et al., 2010).   
The progressive increase of the incidence of this serotype lead some authors to consider 
Salmonella I,4,[5],12:i:- as a possible new pandemic strain (Hopkins, et al., 2010).   
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Data on the number of salmonellosis cases or outbreaks occurring in livestock due to 
Salmonella I,4,[5],12:i:- is not available. This subject needs to be further studied. 
3. Characterization of monophasic Salmonella enterica subsp. enterica 
serovar I,4,[5],12:i:- 
Serotyping divides Salmonella subspecies into subtypes, or serovars, based on the 
immunologic characterization of surface structures, such as O, H and in some cases Vi-
antigens, through the use of polyvalent and monovalent antisera. The full antigenic pool of 
Salmonella [I,4,5,12:i:-] indicates that the somatic O-antigens expressed are I,4,[5],12. The 
underlined O factor 1 (1) means that this factor is determined by phage conversion, being 
present only if the culture is lysogenized by the corresponding converting phage. The factor 
5 between square brackets ([5]) means that the antigen may be present or absent, not having 
a relation with phage conversion. So, in this serovar both factors (1 and 5) can be present or 
absent. 
Most Salmonella strains are biphasic and express two serologically distinct flagellar antigens. 
The two antigens were historically designated as phases and the expression of two different 
phases is mediated at molecular level by an intricate mechanism unique to Salmonella. The 
regulation of phase 1 and phase 2 antigen expressions is under the control of the 
recombinase Hin. This recombinase facilitates the inversion of a promoter element so that it 
either (i) transcribes fljB (which encodes the phase 2 antigen FljB) and fljA (which encodes a 
repressor of fliC, the gene encoding the phase 1 antigen FliC) (Aldridge et al., 2006; 
Yamamoto & Kutsukake, 2006) or (ii) does not transcribe either of these genes. If the 
orientation of this promoter does not allow the transcription of fljB and fljA, the lack of 
repression of fliC transcription leads to the expression of phase 1 flagellar antigens. 
Strains expressing both flagellar types are called biphasic. In contrast, strains defined as 
monophasic fail to express either phase 1 or phase 2 flagellar antigens. S. [1,4,5,12:i:-] 
possess only the phase 1 of the H-antigen “i” and lacks the second phase H antigen, encoded 
by fljB, which either is not present or contains mutation(s) affecting its expression. In 2007, 
Zamperini et al. screened S. 4,[5],12:i:– isolates for phase 1 and phase 2 antigen genes, fliC 
and fljB,  and found that 100% of the isolates were positive for fliC, while 11% were positive 
for fljB. Approximately 89% of these isolates contained complete or partial deletions of the 
phase 2 flagellin gene, fljB, whereas 96% possessed the upstream gene, hin, which encodes 
the DNA invertase involved in "flipping" the fljB promoter.   
Phage typing is a method also used for Salmonella typing based on the lysis of isolates with a 
panel of bacteriophages. Since this technique does not depend on the presence of the second 
phase H antigen, monophasic Salmonella reactions are performed with the same panel of 
phages used for Salmonella serovar Typhimurium (Echeita et al., 2001; Amavisit et al., 2005; 
Mossong et al., 2006). Thus, all phage types that have been recognized so far within 
monophasic Salmonella have also been found in S. serovar Typhimurium. 
For example, the multidrug-resistant Salmonella 4,[5],12:i:– strain detected in Spain in 1997 
was lysed by the S. Typhimurium phage 10 (Echeita et al., 2001). Phage type U302 was also 
detected among S. 4,[5],12:i:– isolates in other countries, such as Denmark (Ethelberg et al., 
2004) and Italy (Dinosi et al., 2009). This phage type has been considered closely related to 
DT104 (Briggs & Fratamico, 1999). 
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However, S. 4,[5],12:i:– isolates have also been classified in other phage types linked to S. 
Typhimurium. In Germany, Hauser et al. (2010) analyzed S. [4,[5],12:i:– isolates obtained 
from different sources (human, swine and pork) and classified 70% of strains as DT193 and 
19% as DT120. In another study, Hopkins et al., (2011) screened a large number of S. 
4,[5],12:i:– strains from different countries (France, The Netherlands, England and Wales, 
Germany, Italy, Spain and Poland), obtained from similar sources as described by Hauser et 
al. (2010), and were able to identify 16 different phage types. However, the most commonly 
identified phage types were DT193, DT120 and RDNC (“Reaction Does Not Conform”). 
DT193 was the most common phage type identified in England and Wales, France, 
Germany, Spain and the Netherlands, while DT120 predominated in Italy and Poland. In 
other studies, S. 4,[5],12:i:– DT193 strains were also isolated from human cases of infection 
and/or pigs in United Kingdom, Luxembourg, United States and Spain (Hampton et al., 
1995; Gebreyes & Altier, 2002; de la Torre et al., 2003; Mossong et al., 2006), while 
monophasic DT120 strains were identified in Italy (Dionisi et al., 2009). 
According to serological characterization, it is difficult to identify the origin of the 
monophasic strains. This strain may be a new variant of the rare serovar Lagos (4,[5],12:i:–), 
or a new variant of the very common serovar Typhimurium [4,5,12:i:1,2], or even a new 
variant of other serovars with similar antigenic pools, such as S. Agama [4,12:i:1,6], S. Farsta 
[4,12:i:e,n,x], S. Tsevie [4,12:i:e,n,z15], S. Cloucester [1,5,12,27:i:l,w], S. Tumodi [1,4,12:i:z6] or 
as S. 4,5,27:i:z35, an unnamed serotype (Switt et al., 2009). However, large scale studies 
suggest that S. 4,[5],12:i:– is genetically related to Typhimurium [4,5,12:i:1,2], and is likely to 
have originated from a S. Typhimurium ancestor (Echeita et al., 2001; Zamperini et al., 2007). 
Monophasic Salmonella could have evolved by two distinct pathways. It could represent 
ancestral forms which did not acquire, though evolution, a second flagellar antigen or the 
required switching mechanism. Alternatively, it could originate as mutants of biphasic 
Salmonella, which have lost either the switching mechanism or the ability to express the 
second flagellar antigen (Burnens et al., 1996). 
The atypical fljB-negative and multidrug-resistant S. 4,[5],12:i:– which emerged and spread 
in Spain in 1997 had a unique sequence specific for S. Typhimurium phage types DT104 and 
U302 and also an IS200 fragment located in a Typhimurium serovar-specific location. Both 
facts strongly suggest that these strains are monophasic variants of S. Typhimurium (Echeita 
et al., 2001). 
On other hand, S. 4,[5],12:i:– DT193 and DT120 strains were classified as monophasic 
variants of S. Typhimurium due to the presence of a Typhimurium-specific fragment of the 
malic acid dehydrogenase gene (Hopkins et al., 2011). However, these strains were negative 
for the DT104- and U302-specific region. Houser et al. (2010) indicated that phage type 
DT193 and DT120 isolates of both serovars presented genetic differences and represent 
different Pulsed-field Gel Electrophoresis (PFGE) clusters. Such differences seem to indicate 
that the S. Typhimurium phage type DT193 lineage was not a direct ancestor of the 
monophasic phage type DT193. In contrast, S. 4,[5],12:i:– phage type DT120 strains showed a 
higher genetic similarity with the S. enterica Typhimurium phage type DT120 strains, 
suggesting that this biphasic subtype was the recent common ancestor of the monophasic 
variant. 
Different mutations and deletions have been associated with the lack of phase 2 flagella 
expression in S. 4,[5],12:i:– isolates. Specifically, some Spanish S. 4,[5],12:i:– isolates appear 
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to be characterized by the deletion of a large fragment, that included fljB, hin, and a DNA 
invertase essential for fljB expression (Garaizar et al., 2002). Most USA isolates characterized 
so far also present deletions that eliminate fljB but maintain hin (Zamperini et al., 2007; 
Soyer et al., 2009). These genetic differences among American and Spanish S. 4,[5],12:i:– 
isolates have also been made evident by PFGE typing (Soyer et al., 2009). Genetic data 
indicate that American and Spanish isolates represent different clonal groups with distinct 
genome deletion patterns. This is consistent with the observation that most Spanish S. 
4,[5],12:i:– isolates are phage type U302 (Echeita et al., 2001). Moreover, PFGE and Multiple-
Locus Variable Number Tandem Repeat Analysis (MLVA) techniques showed that Spanish 
phage type U302 strains seem to be more homogeneous than groups constituted by isolates 
from other countries (Soyer et al., 2009), supporting a clonal origin. Soyer et al. (2009) 
suggested that Spanish Salmonella 4,[5],12:i:– strains might have emerged from a multidrug-
resistant S. Typhimurium strain, while American S. 4,[5],12:i:– strains might have emerged 
from a non-drug-resistant S. Typhimurium strain, through independent events. 
Strains belonging to S. 4,[5],12:i:– that have been recently implicated in infections both in 
humans and farm animals have been further typed using genetic techniques. Guerra et al. 
(2000) studies showed a high genetic homogeneity among 16 Spanish S. 4,[5],12:i:– isolates 
using techniques such as ribotyping, RAPD (Random Amplified Polymorphic DNA 
analysis) and plasmid profiling. However, the use of PFGE techniques could originate 
degrees of heterogeneity that may range from moderate to high, even when applied to 
strains from a single country (Agasan et al., 2002; de la Torre et al., 2003; Zamperini et al., 
2007; Soyer et al., 2009). For example, at least 13 different XbaI PFGE types were found 
among 32 S. 4,[5],12:i:– isolates from Georgia (Zamperini et al., 2007), 44 different XbaI PFGE 
types were detected among 148 isolates from Germany (Hauser et al., 2010) and at least 11 
XbaI PFGE types were found among 23 Spanish S. 4,[5],12:i:– isolates (de la Torre et al., 
2003). Despite their heterogeneity, S. 4,[5],12:i:– strains have been reported to be less 
heterogenic than S. Typhimurium strains (Guerra et al., 2000; Agasan et al., 2002; Soyer et 
al., 2009; Hauser et al., 2010). 
Studies also have showed the occurence of common genetic profiles among S. 4,[5],12:i:– 
isolates obtained from different sources and countries. Zamperini et al. (2007) studies 
revealed the same PFGE profile among poultry and bovine S. 4,[5],12:i:– isolates. In 2011, 
Hopkins et al. compared isolates from humans, pigs and pork using PFGE and detected 
several prevalent genetic profiles common to these three sources (StYMXB.0131, 
STYMXB.0083, STYMXB.0079, STYMXB.0010, STYMXB.0022). Moreover, these profiles were 
detected in isolates from different countries. One PFGE profile, STYMXB.0010, was 
identified in isolates obtained in all the countries surveilled in the referred study. However, 
the authors also found some country-specific differences in the distribution of PFGE 
patterns. For example, nine of the 12 STYMXB.0079 strains originated from Italy, three of the 
five Polish strains were STYMXB.0010 and six of 10 strains from the Netherlands were 
STYMXB.0131. The STYMXB.0079 profile was also the predominant one among 146 human 
S. 4,[5],12:i:– isolates obtained in Italy by Dionisi et al. (2009). 
Typing of monophasic strains using molecular techniques, such as PFGE, have showed that 
these strains differ from S. Lagos strains (Soyer et al., 2009). Data also showed the 
occurrence of some profiles common to S. Typhimurium. Zamperini et al. (2007) examined 
isolates of S. 4,[5],12:i:– and S. Typhimurium collected from animal sources that presented 
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the same PFGE profile. In another study, Agasan et al. (2002) compared the PFGE profile of 
S. 4,[5],12:i:– strains found in humans in New York City to the profile of S. Typhimurium 
isolates, including S. serovar Typhimurium DTI04, and found that S. 4,[5],12:i:– isolates 
were related to some of the S. Typhimurium isolates examined. Amavisit et al. (2005) 
compared the PFGE profiles of human isolates identified as S. Typhimurium DTI04, 
Typhimurium U302 and 4,[5],12:i:–, showing that four of the S. 4,[5],12:i:– isolates presented 
the same or similar profiles as S. Typhimurium phage type U302. 
In another study, Alcaine et al. (2006) used Multilocus Sequence Typing (MLST) to show 
that ST6 type comprises not only bovine and human S. 4,[5],12:i:– isolates but also 
Typhimurium isolates obtained in the United States. ST6 was unique to S. Typhimurium 
and 4,[5],12:i:–, which supports the initial findings based on characterization of Spanish 
isolates (de la Torre et al., 2003), that S. [4,5,12:i:-] may have emerged from a S. 
Typhimurium ancestor. A MLST technique based on four genes applied to American and 
Spanish isolates belonging to S. 4,[5],12:i:– and to S. Typhimurium classified the vast 
majority of isolates as ST1 (Soyer et al., 2009). Similar results were obtained with other 
molecular fingerprinting techniques e.g. RAPD analysis, plasmid profiling (Sala, 2002; de la 
Torre et al., 2003), MLST (Alcaine et al., 2006) and MLVA/Variable Number of Tandem 
Repeats (VNTR) typing (Laorden et al., 2009; Torpdahl et al., 2009; Hauser et al., 2010; 
Hopkins et al., 2011). All these studies lead to the conclusion that S. 4,[5],12:i:– isolates 
belong to a single genetic lineage or clone and seem closely related to S. Typhimurium 
(Zamperini et al., 2007; Dionisi et al., 2009; Hopkins et al., 2011). 
Overall, the genomic characterization of S. 4,[5],12:i:– isolates suggests that this serovar is 
likely to gather several clones or strains that have independently emerged from S. 
Typhimurium during the last two decades, and have changed through multiple 
independent events involving different clonal groups (Garaizar et al., 2002; Laorden et al., 
2009; Laorden et al., 2010). Although the driver for this evolution remains to be enlightened 
for many epidemic strains antimicrobial resistance may be implicated (Zaidi et al., 2007; 
Bailey et al., 2010). 
4. Antimicrobial resistance traits of Salmonella I,4,[5],12:i:- 
The characterization of zoonotic bacteria virulence factors, including the presence of 
antimicrobial resistance traits, is of major importance for assuring the safeguard of health in 
the wider concept of “one health”. The dissemination of antimicrobial resistant bacteria is a 
well-recognized hazard for public and animal health. 
Several Salmonella serovars are frequently related to human and animal diseases, and this 
genus is recognized worldwide as a major foodborne pathogen. Gastroenteritis due to 
Salmonella is usually characterized by mild to moderate self-limiting symptoms, such as 
diarrhea, abdominal cramps, vomiting and fever. However, some strains are responsible for 
severe infections, such as septicemia, osteomyelitis, pneumonia, and meningitis that occur, 
especially in children and in elderly and immunocompromised individuals (Folley and 
Lynne, 2008a). 
Generally, salmonellosis cases caused by Salmonella I,4,[5],12:i:- strains are severe, requiring 
hospitalization (EFSA, 2010b). The control of severe infections requires antimicrobial 
therapy, generally with fluoroquinolones or ceftriaxone, administrated to children in order 
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to avoid the cartilage damage frequently associated with fluoroquinolone therapy (Folley 
and Lynne, 2008a). Therefore, Salmonella represents a bacterial genus of special concern 
regarding antimicrobial resistance dissemination. 
This serotypes’ resistance profiles may vary, worldwide, from 100% susceptible to 
multidrug resistance. Although S. Typhimurium resistance levels have been decreasing in 
several European countries, the incidence of resistant S. Typhimurium I,4,[5],12:i:- strains 
seems to be escalating (Switt et al., 2009). There are only a few studies available on 
antimicrobial resistance traits and genes present in antimicrobial drug–resistant Salmonella 
serotype 4,[5],12:i:– isolates, which have identified some specific resistance genes and 
genetic mechanisms. The limited data available still hasn’t allowed researchers to identify 
the common ancestor responsible for the emergence of 4,[5],12:i:– isolates with a multidrug 
resistance pattern (MDR), information essential to understand resistance evolution and 
dissemination (Switt et al., 2009). 
Antimicrobial resistance in Salmonella spp. may be due to several resistance determinants 
that can be located either in the bacterial chromosome or in plasmids (Folley and Lynne, 
2008a; Switt et al., 2009). These genetic determinants can be responsible for the expression of 
intrinsic resistant mechanisms, related to the production of ß -lactamases, to the 
modification of the antimicrobial compound by bacterial enzymes, to the variation of 
bacterial permeability, to the presence of efflux pumps or to the modification of target 
receptors (Folley and Lynne, 2008a). 
Antimicrobial resistance may also result from the expression of acquired resistance 
mechanisms, emerging through the occurrence of point mutations in chromosomal genes or 
the acquisition of mobile elements such as plasmids, transposons, and genomic islands 
(Switt et al., 2009). The transfer of resistance determinants may occur directly from the same 
or different bacterial species/genera, or indirectly through the environment (Folley and 
Lynne 2008a; EFSA, 2010b). Intestinal microbiota from humans and animals is often exposed 
to antimicrobial compounds of different classes, concentrations and exposure frequencies, 
used for therapy, prophylaxis or methaphylaxis. This exposure may derive from food/feed 
products or from the environment (Martins da Costa et al., 2007). Emergence, selection and 
dissemination of antimicrobial resistant bacteria are still mainly attributed to the selective 
pressure of antibiotic misuse and abuse (Monroe & Polk, 2000; Sayah et al., 2005), so 
intestinal bacteria can became resistant to some antimicrobial compounds, and therefore 
transmit these resistant traits to Salmonella, which occupies the same ecological niche. 
The presence of one or the combination of several of the above mentioned mechanisms may 
also confer a MDR profile to bacteria. These MDR profiles may comprise major 
antimicrobial compounds, hampering the treatment of severe Salmonella infections (EFSA, 
2010b). 
In 1997, MDR Salmonella 4,[5],12:i:– isolates were identified for the first time in Spain 
(Guerra et al., 2001). The most frequent MDR pattern is the ASSuT tetraresistance pattern, 
isolated from 30% of the human infection cases in the last 5 years and also from farm 
animals (Lucarelli et al., 2010; EFSA, 2010b). This pattern emerged in Italy during the 2000s, 
and has already been identified in Denmark, the United Kingdom, the United States, Spain, 
France, and the Czech Republic (Lucarelli et al., 2010). Genes responsible for this MDR 
phenotype are present in a chromosomal resistance island that usually includes the blaTEM, 
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strA-strB, sul2 and tet(B) genes (Hauser et al., 2010; Lucarelli et al., 2010), having some 
strains additional resistances (Lucarelli et al., 2010; EFSA, 2010b). 
Other multirresistant patterns identified in 4,[5],12:i:– isolates worldwide are the 
ACKGSuTm (showing resistance to ampicillin, chloramphenicol, kanamycin, gentamicin, 
sulfamethoxazole and trimethoprim) and ACKGSuTm with additional resistance to 
nalidixic acid patterns, found in Thailand (Switt et al., 2009); the ACSuGSTTm (showing 
resistance to ampicillin, chloramphenicol, sulfamethoxazole, gentamicin, streptomycin and 
tetracycline) and ACGSSuTSTm patterns, found in Spain (Echeita et al., 1999); the ACSSuT 
pattern, found in the United States (Agasan et al., 2002; Switt et al., 2009); and the 
ACSSpSuT pattern, found in the United Kingdom and other countries (Lucarelli et al., 2010). 
The isolation of multiresistant isolates was also described in Brazil (Switt et al., 2009) and 
Germany (Hauser et al., 2010). 
The MDR phenotypes include 4,[5],12:i:– strains harboring class 1 integrons or large 
resistant plasmids, resistant to ampicillin, chloramphenicol, gentamicin, streptomycin, 
sulfamethoxazole, tetracyclines and trimethoprim. These resistance traits are mainly due to 
the expression of blaTEM-1, which codes for broad spectrum b-lactamases responsible for 
resistance to penicillin and amino-penicillins; of blaCTX-M-1, which codes for extended-
spectrum ß-lactamases; of cmlA1, which codes for an efflux pump responsible for 
chloramphenicol resistance; of aac(3)-IV and aadA2, which code for enzymes that modify 
gentamycin and streptomycin active sites, impairing the action of these drugs; of aadA1, sul1 
and sul2, which code for enzymes responsible for resistance to sulfonamides; of sul3 and 
tet(A), which code for an efflux pump mechanism responsible for tetracycline resistance; 
and of dfrA12, which codes for an enzyme responsible for resistance to trimethoprim (Folley 
and Lynne, 2008a; Guerra et al., 2001; Switt et al., 2009). 
It is important to refer that, despite the road book aiming at controlling antimicrobial use 
and abuse, antimicrobial resistance remains a worldwide problem for both human and 
veterinary medicine. In this context, the boundaries between human and animal health, as 
well as between living organisms and the environment are insubstantial. Besides data from 
clinical studies, resistant bacteria have been described from a variety of environmental 
sources, including domestic sewage, drinking water, rivers, and lakes (Sayah et al., 2005). 
5. Salmonella virulence factors 
Salmonella enterica includes many serovars that cause disease in avian and mammalian hosts 
(Eswarappa et al., 2008). Also, Salmonella sp. is one of the most frequent bacterial food-borne 
pathogens affecting humans. In both animal and human hosts, infections may be present in 
a variety of presentations, from asymptomatic colonization to inflammatory diarrhoea or 
typhoid fever, depending on serovar- and host-specific factors. Colonization of reservoir 
hosts often occurs in the absence of clinical signs; however, some S. enterica serovars 
threaten animal health due to their ability to cause acute enteritis or to translocate from the 
intestine to other organs, causing fever and septicaemia (Stevens, 2009). Also, while certain 
serovars of S. enterica are ubiquitary and cause disease in humans and in a variety of 
animals, other serovars are highly restricted to a specific host (Hensel, 2004). For example, 
ubiquitous serovars such as Typhimurium and Enteritidis tend to produce an acute but self-
limiting enteritis in a wide range of hosts, whereas host-specific serovars are associated with 
severe systemic disease that may not involve diarrhoea, usually affecting healthy adults of a 
single species (e.g. S. Typhi in humans, S. Gallinarum in poultry) (Stevens, 2009). 
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Differences in virulence among Salmonella serovars and variations in the evolution of 
Salmonella spp. infections in several host species have been attributed to the acquisition and 
expression of virulence genes (Zhao, 2001). Salmonella spp. virulence requires the coordinated 
expression of complex arrays of virulence factors that allow the bacterium to evade the host’s 
immune system. All Salmonella serotypes share the ability to invade the host by inducing their 
own uptake into the intestinal epithelial cells. In addition, Salmonella serotypes associated with 
gastroenteritis trigger an intestinal inflammatory and secretory response, whereas serotypes 
that cause enteric fever give raise to systemic infections through their ability to survive and 
replicate in mononuclear phagocytes (Ohl & Miller, 2001). 
Many virulence phenotypes of Salmonella enterica are encoded by genes located in distinct 
chromosome regions, organized in 12 pathogenicity islands (Bhunia, 2008; Eswarappa et al., 
2008; Saroj et al., 2008). These gene clusters, known as Salmonella pathogenicity islands 
(SPIs), are thought to be acquired by horizontal gene transfer. They present a G-C content 
that differs from the remaining chromosome, suggesting acquisition by horizontal transfer. 
While some SPIs are conserved throughout the genus, others are specific for certain serovars 
(Amavisit et al., 2003; Bhunia, 2008; Eswarappa et al., 2008). According to Saroj et al., (2008), 
pathogenicity islands can be transferred between bacteria of different genera, leading to an 
accumulation of different virulence mechanisms in some strains. Therefore, the occurrence 
of SPIs varies between serovars and strains (Hensel, 2004). Pathogenicity islands often 
contain multiple genes functionally related, and required for the expression of a specific 
virulence phenotype, which suggests that the acquisition of a pathogenicity island during 
evolution may in one “quantum leap” open up new host niches for the pathogen (Ohl & 
Miller, 2001; Eswarappa et al., 2008). According to Bhunia (2008), the virulence genes 
responsible for invasion, survival, and extraintestinal spread are distributed in the 
Salmonella pathogenicity islands. For instance, the virulence genes that are involved in the 
intestinal phase of infection are located in SPI-1 and SPI-2. Many pathogenicity islands, 
including SPI-1 and SPI-2, encode specialized devices for the delivery of virulence proteins 
into host cells, termed type III secretion systems (TTSSs) (Eswarappa et al., 2008). The 
remaining SPIs are required for causing systemic infections, intracellular survival, fimbrial 
expression, antibiotic resistance, and Mg2+ and iron uptake (Bhunia, 2008). 
Besides the SPIs, some virulence factors can be encoded in virulence plasmids. Six serovars 
(Typhimurium, Gallinarum, Gallinarum biovar Pullorum, Enteritidis, Dublin, Choleraesuis 
and Abortusovis) typically harbor virulence plasmids of 60-95 kb that contain the spv locus, 
which holds some of the genes that are involved in intracellular survival and multiplication 
of this facultative intracellular pathogen (Tierrez & Garcia-del Portillo, 2005). The typical 
virulence plasmid of S. Typhimurium (pSLT90), is about 90-95 kb, and belongs to the FII 
incompatibility group. 
Regarding the monophasic S. Typhimurium, this serotype has only recently emerged, but it 
comprises a wide variety of different strains (Soyer et al., 2008). For that, consistent data on 
virulence mechanisms are limited. Nevertheless, several studies have already shown that 
not only Salmonella serotype 4,[5],12:i:– isolates are genetically and phenotypically closely 
related to Salmonella serotype Typhimurium (Agasan et al., 2002; Amavisit et al., 2005; de la 
Torre et al. 2003; Delgado et al., 2006; Echeita et al., 2001; Zamperini et al., 2007) but also, 
virulence genes of monophasic S. Typhimurium and their variability are identical to those 
found in S. Typhimurium (Garaizar et al., 2002; Hauser et al., 2009; Soyer et al., 2009; Hauser 
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et al., 2010). For example, studies developed by del Cerro et al. (2003) and Guerra et al. 
(2000), demonstrated that strains of monophasic S. Typhimurium presented an homology 
regarding virulence plasmid genes spvC, invE and invA invasion genes, stn enterotoxin 
genes, slyA cytolysin genes and genes associated with survival within macrophages (pho), 
when compared to those typically found in S. Typhimurium 
For all these reasons, it should be noted that, presently, most of the knowledge on SPIs and 
other Salmonella virulence genes of monophasic S. Typhimurium is based on observations 
made in serovar Typhimurium. This serovar is considered a model organism for genetic 
studies, and a wide variety of classical and molecular tools are available for the 
identification and characterization of potential Salmonella virulence genes. 
5.1. Salmonella Pathogenicity Islands 
As above referred, there are at least twelve chromosomally-encoded Salmonella 
pathogenicity islands (SPIs) (Table 2), as follows: 
- SPI-1 is a 43-kb chromosomal locus that was acquired by horizontal gene transfer from 
other pathogenic bacteria during evolution. It contains 31 genes with a major role in the 
invasion of host cells and induction of macrophage apoptosis. It also encodes 
components of the Type III secretion system (TTSS) designated as the Inv/Spa-Type III 
secretion apparatus that includes the secretion apparatus components, effectors, 
chaperones, and regulator (Amavisit et al., 2003; Bhunia, 2008; Eswarappa et al., 2008). 
The major genes present in SPI-1 are invA, invB, invC, invF, invG, hilA, sipA, sipC, sipD, 
spar, orgA, sopB, and sopE. invABCD genes, responsible for the expression of several 
invasion factors that promote bacterial attachment and invasion of M-cells, allowing 
them to cross the epithelial barrier which is the preferential route of Salmonella 
translocation. For example, InvA is an inner membrane protein involved in the 
formation of a channel through which polypeptides are exported. InvH and HilD are 
accessory proteins involved in Salmonella adhesion. InvG is an outer membrane protein 
of the TTSS that plays a critical role in bacterial uptake and protein secretion. 
There are two kinds of effector proteins secreted by the TTSS. One subclass consists of 
InvJ and SpaO, which are involved in the protein secretion through the TTSS. The other 
subclass modulates host cytoskeleton and induces its uptake. SipB and SipC are the major 
proteins, which interact with host cytoskeletal proteins to promote Salmonella uptake. 
Inv/Spa are also responsible for macrophage apoptosis. SipA is an actin-binding protein. 
SopB is an inositol phosphate phosphatase and SopE activates GTP-binding proteins. 
HilA is the central transcriptional regulator of genes located on SPI-1 (Bhunia, 2008). 
- SPI-2 is a 40-kb segment that encodes for 32 genes, only present in members of S. 
enterica, and other type III secretion systems involved in systemic pathogenesis 
(Amavisit et al., 2003; Eswarappa et al., 2008; Bhunia, 2008). The gene products are 
essential for systemic infection and mediate bacterial replication, rather than survival 
within host macrophages (Bhunia, 2008). The majority of these genes are expressed 
during bacterial growth inside the host-cells. SPI-2 carries genes for Spi/Ssa and TTSS 
apparatus, i.e., SpiC, which inhibits the fusion between the Salmonella-containing 
phagosome and the lysosome (Bhunia, 2008). 
- Type III Secretion Systems are expressed by many bacterial pathogens to deliver 
virulence factors to the host cell and to interfere with or subvert normal host cell 
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signaling pathways (Marcus et al., 2000). The TTSS structural genes (including invG, 
prgH and prgK) encode proteins that may form a needle-like structure and are 
responsible for contact dependent secretion or for the delivery of virulence proteins to 
host cells (Zhao, 2001; Bhunia, 2008). This needle-like organelle located in the bacterial 
periphery has four parts: a needle, outer rings, neck, and inner rings. The needle is 
constituted by PrgI and a putative inner rod protein, PrgJ; the outer rings structure by 
InvG; the neck by PrgK; and the base by PrgH that forms the inner rings. The inner 
membrane components include InvC, InvA, SpaP, SpaQ, SpaR, and SpaS proteins 
(Bhunia, 2008). When Salmonella adheres to a target cell, this needle-like structure is 
assumed to form a channel with its base anchored in the cell wall and its tip puncturing 
the membrane of the host cell. Through this channel, Salmonella effectors proteins such 
as SipC, SipA, SopE/E2, and SopB, are injected into the host cell cytoplasm, promoting 
actin polymerization and membrane remodelling which allows the active uptake of 
bacteria by the host cell (Zhao, Y., 2001). 
- SPI-3 is a 17-kb locus conserved between S. enterica serovar Typhi and Typhimurium that is 
also found in S. bongori, being variable in other serovars. SPI-3 harbors 10 genes, including 
the mgtCB operon, which is regulated by PhoPQ and is required for intra-macrophage 
survival and virulence and for magnesium uptake under low magnesium concentrations 
(Amavisit et al., 2003; Bhunia, 2008; Eswarappa et al., 2008). PhoQ is a sensor and PhoP is a 
transcriptional activator that expresses different genes that are required for bacterial 
survival inside the macrophage, as well as in various stressing environments including 
carbon and nitrogen starvation, low pH, low O2 levels, and the presence of defensins. In 
addition, PhoP regulates genes such as spiC and tassC that prevent lysosome fusion with 
the Salmonella-containing vacuole. PhoQ regulon activates pags genes that are essential for 
adaptation during the intracellular life cycle (Bhunia, 2008). 
Salmonella present in the subcellular lamina propria are either engulfed by the 
macrophages or by the dendritic cells, which allows its extraintestinal dissemination. 
The survival of Salmonella within macrophages is generally considered to be essential 
for the translocation of bacteria from the gut-associated lymphoid tissue to the 
mesenteric lymph nodes and from there to the liver and spleen. 
- SPI-4 is a 27-kb locus located next to a putative tRNA gene, containing 18 genes. It is 
thought to encode genes for the Type I secretion system and is suspected to be required 
for intramacrophage survival (Amavisit et al., 2003; Bhunia, 2008). 
- SPI-5 is a 7.6-kb region and encodes six genes. It appears that SPI-5 encodes effector 
proteins for TTSS. SopB, which is translocated by TTSS, is an inositol phosphatase 
involved in triggering fluid secretion responsible for diarrhea. Thus, it is believed that SPI-
5 is possibly responsible for enteric infections (Bhunia, 2008; Eswarappa et al., 2008). 
- SPI-6 is a 59-kb locus present in both serovars Typhi and Typhimurium. It contains the 
saf gene cluster responsible for fimbriae development, pagN responsible for invasion 
traits, and several genes with unknown function (Bhunia, 2008). 
In many studies, bacterial motility was found to be essential for adherence or invasion. 
In many systems, flagella provide the driving force that enable the bacteria to penetrate 
the host mucus layer and reach the host cell surface more rapidly (Zhao, 2001). 
Salmonella expresses different types of fimbriae that promote adhesion to M-cells and 
colonization of intestinal epithelial cells. Type I fimbriae (Fim) binds to α-d-mannose 
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receptor in the host cell; long polar fimbriae (Lpf) bind to cells located in the Peyer’s 
patch; and plasmid-encoded fimbriae (Pef) and curli, thin aggregative fimbriae, aid in 
bacterial adhesion to intestinal epithelial cells. Curli helps bacteria to autoaggregate, 
which enhances survival in the presence of stomach acid or biocides (Bhunia, 2008). 
- SPI-7 or Major Pathogenicity Island (MPI) is a 133-kb locus specific for serovar Typhi, 
Dublin, and Paratyphi. Its genes encode for Vi antigen, a capsular polysaccharide that 
illicits high fever in typhoid fever infections. SPI-7 also carries the pil gene cluster 
responsible for type IV pili synthesis and the gene that encodes for the SopE effector 
protein of TTSS (Bhunia, 2008). 
- SPI-8 is a 6.8-kb locus that appears to be specific for serovar Typhi. It carries genes for 
putative bacteriocin biosynthesis but its functional traits have not been fully 
investigated (Bhunia, 2008). 
- SPI-9 is a locus of approximately 16-kb that carries genes for type I secretion system and 
a large putative RTX (repeat in toxin)-like toxin (Bhunia, 2008). SPI-9 is present in S. 
Typhi, and also as a pseudogene in S. Typhimurium (EFSA, 2010) 
- SPI-10 is a 32.8-kb locus found in serovars Typhi and Enteritidis. It contains genes that 
encode for Sef fimbriae (Bhunia, 2008). 
- Salmonella Genomic Island 1 is a 43-kDa locus that contains genes responsible for 
antimicrobial resistance. It was identified in S. Typhimurium DT104, Paratyphi and 
Agona, which are resistant to multiple antibiotics. The DT104 strain has been implicated 
in outbreaks worldwide. It includes genes responsible for five antimicrobial resistance 
phenotypes (ampicillin, chloramphenicol, streptomycin, sulphonamides, and 
tetracycline) that are clustered in a multidrug resistance region and are composed of 
two integrons (Bhunia, 2008). 
- High Pathogenicity Island (HPI) contains genes responsible for siderophore 
biosynthesis, required for iron uptake. The HPI is found in S. enterica (Bhunia, 2008). 
 
Islands Salmonella serovars Length Kb) Functions
SPI - 1 S. enterica and S. bongori 43 TTSS, invasion of host cells 
SPI - 2 S. enterica 40 TTSS, systemic infection 
SPI - 3 S. enterica and S. bongori 17 Mg2+ uptake, macrophage 
survival
SPI - 4 S. enterica and S. bongori 27 Macrophage survival 
SPI - 5 S. enterica and S. bongori 7.6 Enteropathogeniticity 
SPI - 6 S. enterica subsp. enterica 59 Fimbriae
SPI - 7 S. Typhi, S. Dublin, S. Paratphy 133 Vi antigen
SPI - 8 S. Typhi, 6.8 Unknown; putative bacteriocin 
biosynthesis
SPI - 9 S. Typhy 16.3 Type I secretion system and RTX 
– like toxin
SPI - 10 S. Typhi, S. Enteritidis 32.8 Sef fimbriae
SGI - 1 S. Typhimurium (DT104), S.
Partyphi, S. Agona
43 Antibiotic resistance genes 
HPI S. enterica subsp. IIIa, IIIb, IV ? High affinity iron uptake 
Table 2. Main properties and functions of Salmonella pathogenicity islands (SPI) (Adapted 
from Hensel, 2004 and Bhunia, 2008) 
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Presently, there are over 30 Salmonella specific genes that have been used as targets for PCR 
(Polymerase Chain Reaction) to detect and characterize Salmonella. These include invA gene 
sequences that are highly conserved among all Salmonella serotypes, other gene sequences 
also present throughout the genus, and fimbriae protein-encoding genes and antibiotic 
resistance genes (Table 3). 
 
Gene Description Description 
invA Triggers internalization required for invasion of deep tissue cells 
InvE/A Invase proteins
phoP/Q   Intramacrophage survival and enhanced bile resistance
stnB Salmonella enterotoxin gene
irob Iron regulation
slyA Salmolysin
hin/H2 Flagellar phase variation
afgA Thin aggregative fimbriae
fimC Pathogen related fimbrae gene of S. enterica
sefA Major subunit fimbrial protein of serotype Enterica strains 
pefA Fimbrial virulence gene of S. Typhimurium
spvA Virulence plasmid region 
spvB Virulence plasmid region 
spvC Virulence plasmid region that interacts with the host immune system 
and is responsible for an increased growth rate in host cells 
rep-FIIA Plasmid incompatibility group
sprC Virulence gene
sipB-sipC Junction of virulence genes sipB–sipC
himA Encodes a binding protein
his Salmonella genus specific histidine transport operon
prot6e Virulence plasmid region specific for S. Enteritidis
ST M3357 Regulatory protein whose start codon sequence determines the DT 
phenotype exhibiting enhanced virulence
Table 3. Genes Used for the PCR Identification of Salmonella spp. (Adapted from Levin, 
2010) 
6. Conclusions 
Salmonella spp. is one of the major foodborne pathogen responsible for outbreaks worldwide 
(EECDC, EFSA, 2009; Switt et al., 2009), being estimated to be the main pathogen 
responsible for foodborne mortality in the United States (Mead et al., 1999). This bacterial 
genus includes 2,500 identified serotypes, distributed between 2 species: Salmonella enterica 
and Salmonella bongori (Foley and Lynne, 2008a). The emergence of new pathogenic strains 
and serotypes has been described (EFSA, 2010b; Hauser et al., 2010). Due to their increased 
virulence, these strains can rapidly spread among production animals and humans, 
representing a major public health issue (EFSA, 2010b; Hauser et al., 2010). In the mid-1990s 
the emergence of Salmonella enterica subsp. enterica serotype I,4,[5],12:i:-, a monophasic 
variant of Salmonella Typhimurium, has been reported in Europe (Foley et al., 2008b; Hauser 
et al., 2010; Switt et al., 2009). Nowadays it seems to be one of the major serotypes 
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responsible for human salmonellosis cases worldwide (EECDC, EFSA, 2009; Switt et al., 
2009). It has also been isolated from several animal species, such as poultry, cattle, swine, 
and turtles, and also from food products, such as poultry and pork products. 
In 2010, the European Food Safety Authority (EFSA) Panel on Biological Hazards (BIOHAZ) 
published a Scientific Opinion alerting for the increasing number of outbreaks in the 
European Union member states promoted by “Salmonella Typhimurium-like” strains. The 
Panel has recommended that these strains should be further typed and characterized, 
particularly in terms of antimicrobial resistance (EFSA, 2010b). 
Studies aiming at fully characterizing the monophasic variants of Salmonella Typhimurium-
like strains (4,[5],12:i:–) isolated from different sources, such as food products, animals and 
the environment, in terms of molecular typing, antimicrobial resistance, virulence traits and 
immune response modulation, are extremely relevant. Data provided by such studies will 
have repercussions in preventive and therapeutic strategies, both in human and veterinary 
medicine. 
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